Already a Bloomberg.com user?
Sign in with the same account.
Resverlogix's RVX-208 is aimed at increasing the body's production of this protein, which builds HDL
Now being tested by Merck and Roche, these drugs block enzymes that break down HDL
Molecules that help remove more cholesterol from arteries, under development at Bristol-Myers Squibb and Exelixis
Compounds that mimic HDL's beneficial action, under development at CSL and The Medicines Co.
Data: Company reports